Key facts
- This page summarizes Mark C. Miller's Form 4 filing for Accelerate Diagnostics, Inc (AXDX).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 09 Mar 2023, 15:24.
Mark C. Miller - 07 Mar 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)
- Reporting relationship
- Director
- Issuer ticker
- AXDX
- Reported as of
- 07 Mar 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Mar 2023, 15:24:53 UTC
- Prior SEC filing
- 02 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Steven Reichling, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mark C. Miller filed Form 4 for Accelerate Diagnostics, Inc (AXDX) on 09 Mar 2023.
Change
- Previous filing in this sequence was filed on 02 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AXDX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +50,886
- Change %
- Price
- $0.000000
- Shares after
- 50,886
- Date
- 07 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
AXDX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +4,396
- Change %
- +8.6%
- Price
- $0.000000
- Shares after
- 55,282
- Date
- 07 Mar 2023
- Ownership
- Direct
- Footnotes
- F2
AXDX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 39,062
- Date
- 07 Mar 2023
- Ownership
- By Mark C. Miller Trust, dated April 26, 2002
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AXDX
transaction
Derivative
Employee Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -50,886
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 07 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,886
- Exercise price
- Footnotes
- F1
AXDX
transaction
Derivative
Employee Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -4,396
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 07 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,396
- Exercise price
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the "Vesting Date"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served. This reporting person received a prorated amount of 50,886 RSUs, which is eight of the twelve months.
Footnote F2
The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 4,396 RSUs. All of the RSUs vested on the first-year anniversary of the Date of Grant. These RSUs are subject to the Company's Director Equity Deferral Program and were released within 30 days of separation from service.